Recurrent malignant fibrous histiocytoma of maxillary sinus a rare case angiomatoid fibrous histiocytoma pathology report bala international journal of oral and maxillofacial pathology

Malignant fibrous histiocytoma is a high-grade and aggressive sarcoma. It is a type of histiocytoma that is the most angiomatoid fibrous histiocytoma pathology common soft tissue sarcoma of late adult life. These tumors rarely involve the head and neck region. Wide excision followed by postoperative radiotherapy is believed to be angiomatoid fibrous histiocytoma pathology the treatment of choice for malignant fibrous histiocytoma. We present a rare case of malignant fibrous histiocytoma of angiomatoid fibrous histiocytoma pathology the maxillary sinus in a 72 year old female with angiomatoid fibrous histiocytoma pathology recurrence.

Sekar bala, dominic augustine, murali S. Recurrent malignant fibrous histiocytoma of maxillary sinus – A rare case report.. International journal of oral maxillofacial pathology; 2011:2(3):42-46. ©international journal of oral and maxillofacial pathology. Published by publishing division, celesta software private limited. All rights reserved.

Malignant fibrous histiocytoma (MFH) is a high grade and aggressive sarcoma originally described by angiomatoid fibrous histiocytoma pathology O’brien and stout in 1964. 1 MFH accounts for 20 – 24% of soft-tissue sarcomas, making it the most common soft tissue sarcoma occurring in angiomatoid fibrous histiocytoma pathology late adult life between 50 – 70 years and extremely rare in childhood. It is more commonly seen in males than in females angiomatoid fibrous histiocytoma pathology and is seen more often in caucasian than those of angiomatoid fibrous histiocytoma pathology african or asian descent. MFH occurs most commonly in the extremities (70 – 75%) with lower extremities accounting for 59% of cases, followed by the retroperitoneum. 1 tumors typically arise in deep fascia or skeletal muscle. MFH has been reported to occur in the lung, kidney, bladder, scrotum, vas deferens, heart, aorta, stomach, small intestine, orbit, CNS, paraspinal area, dura mater, facial sinuses, nasal cavity, oral cavity, nasopharynx, and soft tissues of the neck. 2

It has been estimated that approximately 1-3% of these tumours occur in the head and neck region. 3 although previous large retrospective studies indicating a local recurrence angiomatoid fibrous histiocytoma pathology rate of nearly 50% have been reported, recent studies from cancer centres indicate a lower rate. Data derived from M.D.Anderson cancer center memorial sloan showed a recurrence rate of angiomatoid fibrous histiocytoma pathology 19 – 31% and a metastatic rate of 31 – 35%. 3

The clinical predictors of a poor outcome include advanced age, male gender, underlying systemic illness, large primary tumors, tumors arising from the bones, deep-seated tumors, and a history of previous radiation. 4 microscopically, MFH ca n be classified into five types: pleomorphic storiform, giant cell, inflammatory, angiomatoid and myxoid. The combination of infrequent occurrence, varied pathologic features, uncertain histogenesis, subtypes and the many potential sites of presentation make these angiomatoid fibrous histiocytoma pathology tumors a challenge for the diagnostician, surgeon and oncologist. We present a rare case of malignant fibrous histiocytoma of angiomatoid fibrous histiocytoma pathology the maxillary sinus in a 72 year old female with angiomatoid fibrous histiocytoma pathology recurrence.

A 72 year old female visited the oral maxillofacial pathology angiomatoid fibrous histiocytoma pathology department with a chief complaint of a lump and intermittent angiomatoid fibrous histiocytoma pathology pain on the right side of the face since 2 angiomatoid fibrous histiocytoma pathology months. Her medical history was non-contributory. Her past medical history was insignificant to the current lesion. Patient was ambulatory. On extraoral examination a diffuse ill-defined oval swelling measuring 3 x 4 cm was seen angiomatoid fibrous histiocytoma pathology on the right side of the face extending from the angiomatoid fibrous histiocytoma pathology inferior border of the zygomatic arch superiorly to 1 cm angiomatoid fibrous histiocytoma pathology below the ala of the nose inferiorly obliterating the nasolabial angiomatoid fibrous histiocytoma pathology fold. It extended anteriorly from the anterior wall of the right angiomatoid fibrous histiocytoma pathology maxillary sinus and 2 cm short of the tragus posteriorly. Epistaxis and nasal discharge was noticed in the right nostril. Intraoral examination revealed a small bulge in the right palatal angiomatoid fibrous histiocytoma pathology region measuring 3 x 3.5 cm oval in size extending onto the alveolus and angiomatoid fibrous histiocytoma pathology obliterating the buccal vestibule. On palpation the mass was firm, non-fluctuant, non-tender and immobile. No discharge was present. No lymph nodes were palpable.

The right maxillary sinus was hazy and cloudy in appearance. Invasion of the lateral wall of the nose and deviation angiomatoid fibrous histiocytoma pathology of the nasal septum was seen. Destruction of the floor of the sinus and encroachment onto angiomatoid fibrous histiocytoma pathology the orbital floor was observed. A provisional diagnosis of carcinoma of the maxillary sinus and angiomatoid fibrous histiocytoma pathology a differential diagnosis of a low grade sarcoma was made angiomatoid fibrous histiocytoma pathology respectively. Routine blood investigations showed a haemoglobin level of 9 mg/dl with mild leucocytosis. The platelet count, fasting and post prandial blood sugar levels and urine examination angiomatoid fibrous histiocytoma pathology was normal with no significant findings.

An incisional biopsy was performed under local anaesthesia and the angiomatoid fibrous histiocytoma pathology tissue subjected to histopathological examination which revealed a highly cellular angiomatoid fibrous histiocytoma pathology lesion with streaming and sweeping fascicles of dark spindle shaped angiomatoid fibrous histiocytoma pathology cells arranged in a storiform pattern and pale round and angiomatoid fibrous histiocytoma pathology ovoid cells in the background (fig 1). High power view showed pleomorphic spindle shaped fibroblasts which had angiomatoid fibrous histiocytoma pathology features hyperchromatism, altered nuclear cytoplasmic ratio and mitotic figures with multinucleated giant angiomatoid fibrous histiocytoma pathology cells. Large atypical pleomorphic histiocytes were seen in the background (fig 2). A provisional histopathological diagnosis of malignant fibrous histiocytoma was made. The histopathological differential diagnosis included fibrosarcoma and malignant peripheral nerve angiomatoid fibrous histiocytoma pathology sheath tumor. The diagnosis was confirmed after subjecting the tissue for immunohistochemistry angiomatoid fibrous histiocytoma pathology (IHC) which showed positivity for vimentin confirming its mesenchymal origin (fig 3). Other IHC markers when used, showed positivity for alpha-1 antitrypsin (fig 4) and negativity for S100 protein (fig 5). A final diagnosis of malignant fibrous histiocytoma was established.

Computed tomography revealed a radiodense mass in the right maxillary angiomatoid fibrous histiocytoma pathology sinus with extension into the adjacent tissues. The recurrent tumor showed destruction of the orbital floor and angiomatoid fibrous histiocytoma pathology erosion of the floor of the right maxillary sinus, extension into the ethmoidal sinus was seen. There was des truction of the nasal septum. Surgery with radiotherapy has been planned again.

This tumor usually occurs as a painless mass with progressive angiomatoid fibrous histiocytoma pathology growth that habitually has a history of less than six angiomatoid fibrous histiocytoma pathology months. MFH typically arises in soft tissues, especially in the extremities and the trunk. 6 it is relatively rare in the head and neck angiomatoid fibrous histiocytoma pathology region, where the most commonly affected sites are the sinonasal tract, craniofacial bones, larynx, and the soft tissues of the neck. 6 in patients with maxillary sinus tumors, the most frequent symptom at the onset is swelling of angiomatoid fibrous histiocytoma pathology the cheek, followed by nasal obstruction, nasal discharge, and epistaxis. These features were in accordance with our case reported here.

Most maxillary sinus tumors are squamous cell carcinomas, which radiographically show an obscure tumor margin, a necrotic area and an infiltrating growth into the surrounding angiomatoid fibrous histiocytoma pathology soft tissues. 7 in our case, however, the findings of the computed tomography (CT) scans did not favor a diagnosis of squamous cell carcinoma. The relatively smooth surface, the uniform density, lack of a necrotic area, and clear demarcation from surrounding soft tissues in the CT angiomatoid fibrous histiocytoma pathology images may lead to a misdiagnosis of benign tumors or angiomatoid fibrous histiocytoma pathology low-grade malignant tumors. 7

Although MFH has been accepted as a distinct clinicopathologic entity, the exact histogenesis of this sarcoma remains uncertain. The majority of investigators have favoured primitive cells such as angiomatoid fibrous histiocytoma pathology fibroblasts and histiocyte-like cells as the origin of this tumours. 8 in general, the tumor contains both fibroblast like and histiocyte like cells angiomatoid fibrous histiocytoma pathology in varying proportions, with spindled and rounded cells exhibiting a storiform arrangement. It is classified, based on appearance and predominant cell population, into five different subtypes: storiform-pleomorphic, myxoid, giant-cell, inflammatory and angiomatoid.

Differentiated and more frequently high grade. 9 in the myxoid variant, mesenchymal cells are presenting a myxoid stroma rich in mucopolysaccharides. The myxoid variant also exhibits a certain degree of cellular angiomatoid fibrous histiocytoma pathology pleomorphism, but much less than the previous subtype. It has fewer tendencies to metastasize at a distance and angiomatoid fibrous histiocytoma pathology thus has a better prognosis. In the giant-cell subtype, what is peculiar is the presence of a mixture of angiomatoid fibrous histiocytoma pathology malignant and benign multinucleate cells and in particular, osteoclastic type giant cells associated with stromal cells that resemble angiomatoid fibrous histiocytoma pathology mononuclear histiocytes with variable degrees of anaplasia. 9 the inflammatory variant is characterized by the presence of angiomatoid fibrous histiocytoma pathology abundant neutrophils, plasma cells, lymphocytes and occasionally foam cells in poorly collagenized stroma. The angiomatoid type predominates in subjects under the age of angiomatoid fibrous histiocytoma pathology 40 years. This type usually is low-grade, with areas of bleeding and hemosiderin deposits, together with a pleomorphic fibrohistiocytic population and high mitotic activity. 9 the present case pertained to the storiform variant.

The diagnosis of MFH is based upon the pathologic features angiomatoid fibrous histiocytoma pathology characterized by an admixture of fibroblastic and histiocytic-like cells in a storiform pattern. However, the histologic diagnosis of MFH sometimes is difficult. It should be immunohistochemically differentiated from spindle cell carcinoma, pleomorphic rhabdomyosarcoma, leiomyosarcoma, malignant lymphoma, fibrosarcoma, osteosarcoma, angiosarcoma, pleomorphic liposarcoma and melanoma. Fibrous histiocytoma is typically immunoreactive for vimentin. 10 this was true in our case which showed immunoreactivity angiomatoid fibrous histiocytoma pathology for vimentin confirming its mesenchymal origin. Other IHC markers were used, positivity for alpha-1 antitrypsin was noted and negativity for S100 protein was angiomatoid fibrous histiocytoma pathology also observed.

Radiation-induced sarcoma of the head and neck (RISHN) is a long-term complication of radiotherapy. In 10 patients with features of RISHN, MFH was the most common pathologic diagnosis. The period of latency between initial radiation therapy and diagnosis angiomatoid fibrous histiocytoma pathology of RISHN ranged from 9 – 45 years with a median of 17 years. 11 wanebo et al 12 in a study of 214 angiomatoid fibrous histiocytoma pathology head and neck sarcomas found that the mean survival of angiomatoid fibrous histiocytoma pathology MFH at 5 years was 72%, which is higher than the survival for other, more aggressive ty pes of sarcoma, such as angiosarcoma, osteosarcoma and rhabdomyosarcoma.

The advent of more advanced reconstructive techniques, including free tissue transfer, has made more aggressive surgical resection of these tumors possible. The 5-year survival rate ranges from 35-60%. The clinical stage of the tumor, which is defined by tumor grade, size, and presence of distant metastases, is the most important prognostic factor. Other factors include histologic subtype, method of surgical treatment, anatomic site and depth of the primary tumor. 13 recurrence is usually due to inadequate surgical margins and angiomatoid fibrous histiocytoma pathology lack of radiotherapy.

Malignant fibrous histiocytoma of the head and neck is an angiomatoid fibrous histiocytoma pathology aggressive tumor. Inadequate resection is related to a higher local recurrence rate angiomatoid fibrous histiocytoma pathology and worse prognosis. For that reason, the primary treatment of this type of tumor is resection angiomatoid fibrous histiocytoma pathology as extensive as possible. In case of tumors in which adequate margins are not angiomatoid fibrous histiocytoma pathology possible due to their location or large size, postoperative irradiation may improve control of the disease. The mainstays of treatment for MFH are complete surgical excision angiomatoid fibrous histiocytoma pathology most often supplemented with adjuvant radiation therapy. Chemotherapy is reserved for patients at the highest risk of angiomatoid fibrous histiocytoma pathology disease recurrence or patients that already have recurrence. Favorable prognostic factors that correspond to superior survival include small angiomatoid fibrous histiocytoma pathology tumor size, low grade, extremity location, superficial location, and localized disease. We have reported a case of malignant fibrous histiocytoma of angiomatoid fibrous histiocytoma pathology the maxillary sinus which is rare, with recurrence.

References 1. O’brien JE, stout AP. Malignant fibrous xanthomas. Cancer 1964;17:1445-55. 2. Gibbs JF , huang PP , lee RJ , mcgrath B, brooks J, mckinley B, et al. Malignant fibrous histiocytoma: an institutional review. Cancer invest 2001;19:23-7. 3. Weiss SW, enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978; 41:2250-66. 4. Lin HS, sidhu G,wieczorek RL, galli SRD, kaufman D. Malignant fibrous histiocytoma arising in the upper posterior triangle of angiomatoid fibrous histiocytoma pathology the neck. Ear nose throat J 2001; 80:560-7. 5. Bailey BMW. A rare malignant connective tissue tumour arising in the upper angiomatoid fibrous histiocytoma pathology lip. Br J oral surg 1983; 21:129 – 35. 6. Young YH, hsieh T. Malignant fibrous histiocytoma of the head and neck: report of 5 cases. J formosan med assoc 1989; 88:606-9. 7. Sato T, kawabata Y, morita Y, noikura T, mukai H, kawashima K, et al. Radiographic evaluation of malignant fibrous histiocytoma affecting maxillary alveolar bone: a report of 2 cases. Oral surg oral med pathol oral radiol endod 2001; 92:116-23. 8. Wood GS, beckstead JH, turner RR, hendrickson MR, kempson RL, warnke RA. Malignant fibrous histiocytoma tumour cells resemble fibroblasts. Am J surg pathol 1986; 10:323 – 35. 9. Le doussal V, coindre J-M, leroux A, cols Y. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis. Cancer 1996;77:1823-30. 10. Block MS, cade JE, rodriguez FH. Malignant fibrous histiocytoma in the maxilla: review of literature and report of a case. J oral maxillofac surg 1986;44:404-12. 11. Patel SG, see AC, williamson PA, archer DJ, evans PH. Radiation-induced sarcoma of the head and neck. Head neck 1991;21:346-54. 12. Wanebo HJ, koness RJ. Head and neck sarcoma: report of the head and neck sarcoma registry. Society of head and neck surgeons committee on research. Head neck 1992;14:1-7. 13. Pezzi CM , rawlings MS , esgro JJ , pollock RE, romsdahl MM. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992;69:2098-103.

RELATED_POSTS